Determination of Bisphenol A (BPA) in Infant Oral Hygiene Devices using Fluorescence Spectrophotometry by Thomason, Kaitlyn
Ouachita Baptist University
Scholarly Commons @ Ouachita
Honors Theses Carl Goodson Honors Program
2019
Determination of Bisphenol A (BPA) in Infant Oral




Follow this and additional works at: https://scholarlycommons.obu.edu/honors_theses
Part of the Materials Chemistry Commons
This Thesis is brought to you for free and open access by the Carl Goodson Honors Program at Scholarly Commons @ Ouachita. It has been accepted
for inclusion in Honors Theses by an authorized administrator of Scholarly Commons @ Ouachita. For more information, please contact
mortensona@obu.edu.
Recommended Citation
Thomason, Kaitlyn, "Determination of Bisphenol A (BPA) in Infant Oral Hygiene Devices using Fluorescence Spectrophotometry"
(2019). Honors Theses. 734.
https://scholarlycommons.obu.edu/honors_theses/734
SENIOR THESIS APPROVAL 
This Honors thesis entitled 
Determination of bisphenol A (BP A) in 




and submitted in partial fulfillment of 
the requirements for completion of 
the Carl Goodson Honors Program 
meets the criteria for acceptance 
and has been approved by the undersigned readers. 
Dr. Sara Hubbard, thesis director 
Dt. Tiffany Eurich eccmd reader 
Dr. Rachel Pool, third reader 
Dr. Barbara Pemberton, Honors Program director 
24 April 20 19 
Determination of bisphenol A (BPA) in infant 
oral hygiene devices using fluorescence 
spectrophotometry 




• Ouachita Baptist University 
• Dr. Sara Hubbard 
• Dr. Tiffany Eurich 
• Dr. Rachel Pool 
• Dr. Barbara Pemberton 
Abstract: 
Bisphenol A (BPA) is an organic, solid substance that is structurally similar to estradiol, a 
naturally-occurring form of the female sex hormone estrogen. Since the 1957 discovery that BPA 
can function as an effective hardener, BPA-based plastics have been used to make a variety of 
consumer goods, such as water bottles, baby bottles, DVDs, eyeglass lenses, and medical devices, 
while BPA-based epoxy resins have been used to coat the insides of various food and drink 
containers, to line the insides of water pipes, and to create the thermal ink found on paper sales 
receipts. In recent years, however, numerous studies have suggested that BPA-exposure during 
fetal growth and childhood can lead to later problems like obesity, type 1 diabetes, anxiety, 
depression, hyperactivity, and aggression. While BPA has already been banned from baby bottles, 
no BPA regulations have been placed on children's oral hygiene devices as of yet. Some infant 
oral hygiene devices like toothbrushes claim to be BPA-free, while others do not make any 
statements regarding BPA content. In this research study, a technique was developed to 
determine the presence of BPA in toothbrushes made for infants and toddlers using fluorescence 
spectrophotometry. Using this technique, two different types of toothbrushes were analyzed: 
those labeled BPA-free and those not labeled. It was found that neither toothbrushes showed 
traces of BPA, although the toothbrush with no label showed an upward trend in regards to 
emission intensity that could possibly show the presence of BPA if more time was given in the 
solvent. This thesis will discuss literature detailing the effects of BPA on infant health, the results 
of the fluorescence spectrophotometry study done on the toothbrushes, and future research 




BPA was first created in 1891 by Russian chemist Aleksandr Pavlovich Dian in as a side product of 
the catalyzed condensation reaction of a two-to-one mixture of phenol and acetone in 
concentrated hydrochloric acid (Figure 1).1' 2 
HO OH 
Figure 1. The synthesis of BPA from two phenol molecules and one acetone molecule. 
In 1938, a British chemist by the name of Edward Charles Dodds discovered that BPA and 
estradiol, a naturally-occurring form of the estrogen hormone, shared similar chemical 
features-namely their phenol groups 
(Figure 2).2'3 He soon began developing 
BPA to be a form of synthetic estrogen, 
although this endeavor was short-term, 
as another compound was found to 
produce better results. Interestingly, this 
compound would be later banned by the 
FDA in 1979 as it was found to be linked 
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Figure 2. The chemical structures of BPA and estradiol, with the 
blue regions showing the structural similarities. 
Less than twenty years later, however, one discovery would drastically change the 
applications of BPA forever. In 1953, chemists Dr. Hermann Schnell of Bayer and Dr. Daniel Fox 
of General Electric independently discovered how to use BPA to create a hard resin called 
polycarbonate by combining BPA with 
phosgene (Figure 3).4 This hard resin 
was clear and rigid like glass, although 
much lighter and shatter-resistant. It 
was also more affordable than glass 
and thus easier to replace if broken. 
This polycarbonate product first 
appeared in the electrical industry in 






Figure 3. The reaction of BPA and phosgene in basic solution results in 
the formation of polycarbonate, a strong plastic used in many 
consumer good. 
connectors.4 In the 1960s, the Food and Drug Administration (FDA) approved polycarbonate to 
be used in food packaging, and it was this that launched a world-wide boom in BPA-exposure.4 
BPA became increasingly popular in consumer goods, and the estrogenic properties 
revealed by Dodds were ignored for nearly thirty years. This would soon change, however, in 
1993, when Dr. David Feldman, a medical doctor and Stanford University professor discovered 
the leaching properties of BPA.4 In a study to find estrogen-producing yeast, Feldman and his 
team were growing yeast in plastic flasks and noticed an estrogenic molecule in the growth 
medium.5 After isolating the molecule and analyzing it with the use of nuclear magnetic 
resonance spectroscopy and mass spectroscopy, the team found that the molecule was BPA.5 
Successive testing done using flasks containing only distilled water showed that the presence of 
BPA was not dependent on either the yeast or the growth medium.5 This also disproved that the 
BPA was being synthesized by the yeast. Feldman and his team then repeated the studies using 
glass flasks in place of plastic and found no traces of BPA.5 These findings led to the conclusion 
that BPA was being leached from the polycarbonate plastic and into the contents of the flask 
during the heating of the autoclaving process.5 Also alarming was the revelation that BPA could 
bind to the estrogen receptors in rat uterus, as Feldman and his team discovered, which indicated 
that BPA was not just a form of synthetic estrogen but also an endocrine disruptor.5 
BPA as an Endocrine Disruptor 
Endocrine disruptors are chemicals that hinder the normal functioning of the endocrine 
system, usually by interfering with hormones. The most common way is through competitive 
inhibition (Figure 4). In this mechanism, the 
endocrine disrupter binds to a hormone 
receptor, thus inhibiting the hormone from 
binding and initiating its normal response. 
BPA acts as an endocrine disrupter 
to the two types of estrogen receptors 
(ERs): ERa and ER/3 .6 Both of these 
receptors are ligand-activated, meaning 
that the binding of a ligand (i.e., estrogen) 
causes them to undergo a change in 
\ Endocrtne ~ Dlsruptor 
Figure 4. An endocrine disrupter exhibiting competitive 
inhibition. 
conformation. 6 After this shape change, the receptors are able to migrate into the nucleus of the 
cell. It is here that the ERs act as transcription factors, interacting with activators and repressors 
associated with the target gene. If a transcription factor binds to an activator, the expression of 
the target gene increases, while the binding of a transcription factor to a repressor causes the 
expression to decrease. 
Because the structural configuration of BPA is so similar to that of estrogen, the body is 
unable to distinguish between the two. As a result, BPA is able to successfully bind to both ERa 
and ER/3. However, because BPA and estrogen are not identical, the binding of BPA causes each 
type of ER to undergo a different conformation change. 6 When BPA binds to ERa, the receptor 
undergoes the same conformation change as would normally occur with estrogen as the ligand. 
Therefore, BPA acts agonistically to ERa, meaning that the binding of BPA to ERa initiates the 
same types of responses in the body as would occur if there were high levels of estrogen present, 
thus increasing estrogenic-related activities. On the other hand, the binding of BPA to ER/3 causes 
an alteration in the receptor's conformation change, resulting in no response to occur. In this 
way, BPA acts antagonistically to ER/3, meaning that the binding of BPA to ER/3 mimics that of 
having no estrogen present in the body, thus inhibiting estrogenic-related activities. 
Effects of BPA on the Bodv 
Although the discovery ofthe harmful nature of BPA is relatively recent, numerous studies 
have already been performed concerning the health risks of BPA exposure. In a study done by 
Kristin Junge and team, prenatal BPA exposure was found to be linked to obesity.7 In this study, 
408 infants were analyzed based on the levels of BPA they had been exposed to during prenatal 
development, as was determined by urine samples from the mothers. At birth, cord blood 
samples were taken from these infants, and the DNA methylation of these samples was 
measured using MassARRAY. The results revealed that infants exposed to higher levels of BPA 
during prenatal development 
showed decreased methylation 
in the CpG islands associated 
with the promoter regions of 
MEST genes.l CpG islands are 
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Figure 5. The methylation of CpG islands greatly controls transcription. 
short segments of DNA that precede promoters, and the degree of methylation at these regions 
partly dictates whether a gene can be transcribed into RNA (Figure 5). When the CpG islands of 
a particular gene are highly methylated, transcription factors are unable to interact with the 
promoter and cannot turn it on, thereby inhibiting the transcription of the gene. When the CpG 
islands are unmethylated or hypomethylated, however, the promoter is more accessible to 
transcription factors, allowing transcription to freely occur. The' MEST gene is said to control 
adipocyte size and thus the development of adipose tissueJ When the CpG islands associated 
with the MEST promoters are hypomethylated due to prenatal BPA-exposure, an increase in 
MEST RNA expression occurs, resulting in the accumulation of large amounts of fat cells and fat 
tissue. This increased MEST expression was found evident in the BMI studies conducted on the 
infants at age one, which found that the infants who had been exposed to greater levels of BPA 
during development showed higher BMI scores than their less-exposed cohorts.7 
BPA has also been linked to the development of type 1 diabetes. In a study performed by 
Johanna Bodin and team, healthy weight, non-diabetic infant mice were administered doses of 
BPA via drinking water (1 mg/L) over the course of 35 weeks--doses considered to be under the 
Fluorescence Spectroscopy 
Fluorescence is the light energy given off when a certain type of compound absorbs 
energy, usually in the form of light or radiation. When the electrons in a fluorescent compound 
absorb a specific wavelength of energy, they become excited and begin to vibrate, moving from 
their ground energy state to a higher energy state. In fluorescence spectroscopy, the compound 
is excited by photons of light, causing the electrons to transition to a higher energy state. The 
electrons remain in this higher energy state for a short period of time, approximately 10-8-10-4 
seconds, before then losing energy 
and returning back to their ground 
state. The lost energy is released in 
the form of fluorescence (Figure 6). 
Because this emitted energy is less 









Figure 6. Jablonski energy diagram illustrating fluorescence. 
energy, the wavelength ofthe emitted fluorescent light is greater, due to the inverse relationship 
between energy and wavelength. 
The wavelength of the emitted fluorescence is unique for every compound. Previous 
research performed at Ouachita 6000 
Baptist University found that BPA 5000 
·i 4000 
fluoresces at excitation and emission 






nm, respectively (Figure 8). Therefore, 
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it is possible to determine the 
Figure B. Excitation and emission spectra of BPA in methanol water. 
presence of BPA in a sample by examining the wavelengths of the emitted fluorescence. If a 
sample contains BPA, the emission 
wavelengths will be 310 nm when 
excited by wavelengths of 278 nm. 
This can be tested using a 
fluorescence spectrophotometer 
(Figure 9). Within this instrument, a Figure 9. The mechanism of a fluorescence spectrophotometer. 
light source is emitted onto a prism and then a filter, which separates the light into a specified 
wavelength (278 nm, in this case). This specific wavelength is then directed to the sample, which 
is contained within a quartz cuvette. The electrons in the sample will become excited, travel to 
an increased energy state, and then release light energy on their way back to their ground state, 
as previously mentioned. This emitted light is passed through a detector, which records the 
wavelength. If the sample contains BPA, this wavelength will be approximately 310 nm. 
Materials and Methods: 
In order to become familiarized 
with the instrument and to set a 
standard for the rest ofthe fluorescence 
intensity values, a calibration curve was 
created using known concentrations of 
BPA: 0 M, 1.5 M, 3.04 M, and 4.56 M 






Fluorescence Calibration Curve of BPA in 
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Figure 10. Fluorescence calibration curve of BPA. 
5 
made using 0 ml, 2 ml, 4 ml, and 6 ml of BPA, respectively. All concentrations were run in 
triplicates. 
To begin the study, two toothbrushes designed for infants and toddlers were obtained: 
one labeled BPA-free (Toothbrush A) and one with no label (Toothbrush B). Each toothbrush was 
placed in separate 100-ml beakers containing 100 ml of Milli-Q water. Over the course of one 
week, 10-ml aliquots of the Milli-Q water were taken from each beaker at various times and 
placed in 10-ml volumetric flasks. On the starting day ofthe experiment, samples were taken at 
the onset (time= 0 hours) and then every twenty minutes for two hours (time= 0.33, 0.66, 1.00, 
1.33, 1.66 hours). Samples were then taken every twenty-four hours for three days (time = 24, 
48, 72 hours) and then once more on the seventh day (time= 168 hours). For control, two 10-ml 
samples of Milli-Q water were taken at the start of the experiment (time = 0 hours). Samples 
were analyzed using the FS-5 Spectrofluorometer from Edinburgh Instruments. A portion of each 
sample was pipetted into the quartz cuvette, which was then placed into the instrument. The 
parameters of the instrument were set to include excitation wavelengths of 278 nm and emission 
wavelengths of 310 nm. Samples were done in triplicates, with thorough washings between each. 
Results and Discussion: 
For all samples, the following values were recorded: emission wavelength, emission 
intensity, excitation wavelength, and excitation intensity (Tables 1 & 2). 
Time of Toothbrush Labeled BPA-Free 
Absorbance Emission Emission Intensity Excitation Excitation Intensity 
(Hours) Wavelength (counts/10A3) Wavelength (counts/10A3) 
0 308 267 281 126.3 
0.33 308 I 239 l 280 l 142.7 
0.67 307 l 168 I 280 l 89.96 
1 307 I 158 I 281 I 90.42 
1.33 308 l 154 I 280 l 81.56 
1.67 307 l 171 I 280 l 93.55 
24 307 l 173 I 280 l 86.36 





280 l 98.35 
168 308 181 280 I 97.75 
Table 1. Fluorescence spectrophotometry results for Toothbrush A. 
Time of Toothbrush Not Labeled 
Absorbance Emission Emission Intensity Excitation Excitation Intensity 
(Hours) Wavelength (counts/10A3) Wavelength (counts/10A3) 
0 308 137 280 65.97 
0.33 307 I 166 I 280 l 83.36 
0.67 306 I 130 I 280 I 83.36 
1 308 I 165 I 280 I 86.36 
1.33 307 I 158 I 280 I 92.95 
1.67 307 I 141 I 280 I 84.56 
24 308 I 151 I 279 I 88.15 








168 307 190 281 78.44 
Table 2. Fluorescence spectrophotometry results for Toothbrush B. 
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The toothbrush labeled BPA-free (Toothbrush A) did not show traces of BPA. The 
toothbrush with no label also did not show traces of BPA (Toothbrush B), although the line did 
exhibit an upward progression that could possibly reveal BPA if given more time. 
Summary and Conclusions: 
Bisphenol A is a very prevalent molecule, as it has been used in the widespread 
manufacturing of consumer goods since the 1960s. However, recent research suggests that BPA 
exposure is harmful, as the molecule binds to estrogen receptors in the body and elicits a number 
of estrogenic responses. This is particularly true for infants and children, as they do not have a 
well-developed purification system like adults. Studies show that BPA exposure during 
development leads to increased MEST gene expression, which can result in higher BMI scores 
and thus an increased risk of obesity. Exposure to BPA has also been linked to type 1 diabetes, as 
BPA depletes phagocytic macrophages that serve to lessen hyperglycemia and insulitis. 
Furthermore, infants are being exposed to BPA in many ways, including through the intake of 
both liquid and formula formulas, and by contact with medical devices like those found in the 
neonatal intensive care unit. In 2012, BPA-based plastics were banned from being used in the 
manufacturing of baby bottles. However, no BPA regulations have been places on oral hygiene 
devices made for children . 
In this study, I wanted to determine if BPA was present in toothbrushes designed for 
children. I also wished to see if the toothbrushes labeled BPA-free were truly void of BPA. This 
was an unexplored field, so I first had to design a way to test the toothbrushes for BPA. I then 
used fluorescence spectrophotometry to determine the presence of BPA. 
Future Work: 
In this study, only a single BPA-free labeled toothbrush and a single non-labeled toothbrush were 
tested. Therefore, to get a better understanding of BPA leaching from infant toothbrushes, it 
would be ideal to perform this experiment again with a variety of different brands and styles. 
Furthermore, many infants and toddlers drink a wide variety offruit juices (i.e., apple juice, white 
grape juice, orange juice). For this reason, it would be interesting to determine to what effect the 
acidity ofthese different juices would have on BPA leaching, if any at all. In addition, a gentleman 
at the research conference where I presented inquired about the Milli-Q water that I used. He 
noted that the purity of this water could possibly be inhibiting the leaching of BPA from the 
toothbrush, as there are no impurities for the BPA molecules to interact with. 
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